Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG (2015) International Panel for NMO Diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177–189

Article  PubMed  PubMed Central  Google Scholar 

Gkaniatsou T, Papadopoulou A, Paul F, Brandt AU, Oertel FC (2020) Frequency of autoimmune disorders and autoantibodies in European patients with neuromyelitis optica spectrum disorders. Acta Neurol Belg 120(1):223–225

Article  PubMed  Google Scholar 

Pereira WLCJ, Reiche EMV, Kallaur AP, Oliveira SR, Simão ANC, Lozovoy MAB, Schiavão LJV, Rodrigues PRDVP, Alfieri DF, Flauzino T, Kaimen-Maciel DR (2017) Frequency of autoimmune disorders and autoantibodies in patients with neuromyelitis optica. Acta Neuropsychiatr 29(3):170–178

Article  PubMed  Google Scholar 

Shahmohammadi S, Doosti R, Shahmohammadi A, Mohammadianinejad SE, Sahraian MA, Azimi AR, Harirchian MH, Asgari N, Naser Moghadasi A (2019) Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review. Mult Scler Relat Disord 27:350–363

Article  PubMed  Google Scholar 

Akaishi T, Tarasawa K, Matsumoto Y, Sandhya P, Misu T, Fushimi K, Takahashi T, Fujimori J, Ishii T, Fujimori K, Yaegashi N, Nakashima I, Fujihara K, Aoki M (2023) Associations between neuromyelitis optica spectrum disorder, Sjögren’s syndrome, and conditions with electrolyte disturbances. J Neurol Sci 452:120742

Article  CAS  PubMed  Google Scholar 

Asgari N, Jarius S, Laustrup H, Skejoe HP, Lillevang ST, Weinshenker BG, Voss A (2018) Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: A predominantly population-based study. Mult Scler 24(3):331–339

Article  PubMed  Google Scholar 

Leite MI, Coutinho E, Lana-Peixoto M, Apostolos S, Waters P, Sato D, Melamud L, Marta M, Graham A, Spillane J, Villa AM, Callegaro D, Santos E, da Silva AM, Jarius S, Howard R, Nakashima I, Giovannoni G, Buckley C, Hilton-Jones D, Vincent A, Palace J (2012) Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology 78(20):1601–1607

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wingerchuk DM, Weinshenker BG (2012) The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult Scler 18(1):5–10

Article  CAS  PubMed  Google Scholar 

Chen C, Xiaobo S, Yuge W, Yaqing S, Ling F, Lisheng P, Zhengqi L, Wei Q (2016) Multiple autoantibodies and neuromyelitis optica spectrum disorders. NeuroImmunoModulation 23(3):151–156

Article  CAS  PubMed  Google Scholar 

Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452

Article  CAS  PubMed  Google Scholar 

Cree BAC, Bennett JL, Kim HJ, Weinshenker BG, Pittock SJ, Wingerchuk DM, Fujihara K, Paul F, Cutter GR, Marignier R, Green AJ, Aktas O, Hartung HP, Lublin FD, Drappa J, Barron G, Madani S, Ratchford JN, She D, Cimbora D, Katz E, N-MOmentum study investigators (2019) Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial. Lancet 394(10206):1352–1363. https://doi.org/10.1016/S0140-6736(19)31817-3

Article  CAS  PubMed  Google Scholar 

Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zéphir H, Moder K, Weinshenker BG (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65(1):78–83

Article  PubMed  Google Scholar 

Hinson SR, Lennon VA, Pittock SJ (2016) Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders. Handb Clin Neurol 133:377–403

Article  PubMed  Google Scholar 

Satoh M, Chan EK, Ho LA, Rose KM, Parks CG, Cohn RD, Jusko TA, Walker NJ, Germolec DR, Whitt IZ, Crockett PW, Pauley BA, Chan JY, Ross SJ, Birnbaum LS, Zeldin DC, Miller FW (2012) Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum 64(7):2319–2327

Article  PubMed  PubMed Central  Google Scholar 

Niu D, Kondo T, Nakazawa T, Kawasaki T, Yamane T, Mochizuki K, Kato Y, Matsuzaki T, Takata K, Katoh R (2012) Differential expression of aquaporins and its diagnostic utility in thyroid cancer. PLoS ONE 7(7):e40770

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pache F, Ringelstein M, Aktas O, Kleiter I, Jarius S, Siebert N, Bellmann-Strobl J, Paul F, Ruprecht K (2021) C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD. J Neuroimmunol 360:577699

Article  CAS  PubMed  Google Scholar 

Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554–558

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soyfoo MS, Chivasso C, Perret J, Delporte C (2018) Involvement of aquaporins in the pathogenesis, diagnosis and treatment of sjögren’s syndrome. Int J Mol Sci 19(11):3392

Article  PubMed  PubMed Central  Google Scholar 

Zisimopoulou P, Evangelakou P, Tzartos J, Lazaridis K, Zouvelou V, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Frenkian Cuvelier M, Stojkovic T, DeBaets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A, Szczudlik P, Szyluk B, Lavrnic D, Basta I, Peric S, Tallaksen C, Maniaol A, Tzartos SJ (2014) A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis. J Autoimmun 52:139–145. https://doi.org/10.1016/j.jaut.2013.12.004

Article  CAS  PubMed  Google Scholar 

Verkman AS, Anderson MO, Papadopoulos MC (2014) Aquaporins: important but elusive drug targets. Nat Rev Drug Discov 13(4):259–277

Article  CAS  PubMed  PubMed Central  Google Scholar 

Albuquerque EX, Pereira EF, Alkondon M, Rogers SW (2009) Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 89(1):73–120

Article  CAS  PubMed  Google Scholar 

Wang Z, Yan Y (2017) Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica. Front Immunol 8:1785

Article  PubMed  PubMed Central  Google Scholar 

McKeon A, Lennon VA, Jacob A, Matiello M, Lucchinetti CF, Kale N, Chan KH, Weinshenker BG, Apiwattinakul M, Wingerchuk DM, Pittock SJ (2009) Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve 39(1):87–90

Article  PubMed  Google Scholar 

Iyer A, Elsone L, Appleton R (2014) Jacob A A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica. Autoimmunity 47(3):154–161

Article  CAS  PubMed  Google Scholar 

Ikeguchi R, Shimizu Y, Suzuki S, Shimizu S, Kabasawa C, Hashimoto S, Masuda M, Nagane Y, Utsugisawa K, Suzuki Y, Takahashi T, Utsumi H, Fujihara K, Suzuki N, Uchiyama S (2014) Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis. Clin Neurol Neurosurg 125:217–221

Article  PubMed  Google Scholar 

Brignol TN, Leveziel N, Urtizberea JA (2019) J Fr Ophtalmol 42(3):e131–e132

Article  CAS  PubMed  Google Scholar 

Castro-Suarez S, Guevara-Silva E, Caparó-Zamalloa C, Cortez J, Meza-Vega M (2020) Neuromyelitis optica in patients with myasthenia gravis: two case-reports. Mult Scler Relat Disord 43:102173

Article  PubMed  Google Scholar 

Guo Y, Lennon VA, Popescu BF, Grouse CK, Topel J, Milone M, Lassmann H, Parisi JE, Pittock SJ, Stefoski D, Balabanov R, Lucchinetti CF (2014) Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum. JAMA Neurol 71(8):1025–1029

Article  PubMed  Google Scholar